Table 3.

Percentage of CD4+/CD25+, CD4+/CD28+ lymphocytes, and CD80+ cells of CD14+ population, in PHA-cultures with (a) E. coli LPS and (b) HKBA (results are presented as mean ± SD). NS: nonsignificant.

(a)	E. coli LPS cultures	n	%CD4+/CD25+	%CD4+/CD28+	%CD14+/CD80+
	AB	13	37.2 ± 11.6	43.4 ± 11.3	47.9 ± 19.9
	CB	22	27.9 ± 6.9	35.7 ± 8.0	45.9 ± 23.2
	Cured	11	30.8 ± 12.8	39.8 ± 17.2	21.8 ± 14.4
	Controls	15	27.4 ± 10.5	36.5 ± 14.9	20.9 ± 12.5
			P (AB versus cured) = NS	P (AB versus cured) = NS	P(AB versus cured) = .002
			P (AB versus controls) = .027	P (AB versus controls) = NS	P (AB versus controls) < .001
			P (CB versus cured) = NS	P (CB versus cured) = NS	P (CB versus cured) = .001
			P (CB versus controls) = NS	P (CB versus controls) = NS	P (CB versus controls) < .001
			P (AB versus CB) = .006	P (AB versus CB) = .024	P (AB versus CB) = NS
	CB1	12	26.3 ± 5.9	34.5 ± 8.7	49.9 ± 26.5
	CB2	10	29.9 ± 7.9	37.1 ± 7.2	41.1 ± 18.7
			P (CB1 versus AB) = .008	P (CB1 versus AB) = .039	P (CB1 versus CB2) = NS
					P (CB1 versus controls) = .003
					P (CB2 versus controls) = .004
(b)	HKBA cultures
	AB	13	22.4 ± 11.5	35.9 ± 14.5	30.0 ± 20.8
	CB	22	24.8 ± 6.5	38.8 ± 11.2	36.5 ± 25.5
	Cured	11	24.8 ± 14.8	38.7 ± 17.9	20.9 ± 16.7
	Controls	15	20.6 ± 10.3	35.6 ± 16.9	16.3 ± 13.6
			NS	NS	P (AB versus controls) = .047
					P (CB versus controls) = .004
	CB1	12	24.9 ± 7.6	38.3 ± 13.3	46.6 ± 26.6
	CB2	10	24.7 ± 5.1	39.3 ± 8.7	24.4 ± 18.7
			NS	NS	P (CB1 versus CB2) = .038
					P (CB1 versus cured) = .012
					P (CB1 versus controls) = .003